Latest News

Source: magnific.com  Ask ten UK traders which broker is best and you'll get a range of answers, because the "best" broker genuinely depends on how someone trades. But when you assess brokers against the criteria that matter most to the widest range of UK traders — regulation, track record, execution quality, platform choice and market [...]

GE Vernova is posting record orders and dramatically raising its free cash flow outlook. NextEra is executing steadily but navigating a major merger that won't close for another year.

All signs seem to point to an affirmative answer to that question.

NovoCure (NASDAQ:NVCR) outlined its strategy for returning its glioblastoma franchise to growth, expanding launches in pancreatic and lung cancer, and moving toward profitability during the Morgan Stanley Healthcare Conference. Chief Executive Officer Frank Leonard said the company, founded more th

Canada’s new “one project, one review, one year” approach could finally speed up mine approvals, and Canada Nickel may be an early real-world test.

Micron Technology will soon release its fiscal 2026 results, which could give the stock a nice shot in the arm.

A quarter-point move carries a price tag, and the company previously disclosed it.

Low-cost ETFs BKLC, EDGX, and SPYM offer investors zero or near-zero expense ratios, though liquidity, fee waivers, and trading costs vary across each fund's approach.

Stock has declined 43% over the past year, though the CEO retains $27.8 million in direct holdings after the sale.

AbbVie's immunology franchise is firing on all cylinders while Bristol Myers Squibb navigates revenue declines and legal uncertainty.

Nvidia, Alphabet, and AMD have already bought most of the high bandwidth memory that will be manufactured next year.

Big things are in store for this rare-earth stock in one firm's estimation.

Mark Carney is courting global capital for Canada. Here's why Barrick Gold and Endeavour Mining look attractive to TSX investors right now.

Will rate hikes send the bull market crashing lower?

Choudary sold shares under a pre-scheduled trading plan adopted in April. The CFO retains 958,078 shares worth around $100 million.

Leach exercised 15,142 stock options at $3.99 per share under a pre-established Rule 10b5-1 trading plan, maintaining a direct stake of 823,886 shares worth $32.24 million.

With roughly 15 weeks until New Year's Eve, it's time to begin thinking about your next required minimum distribution.

Ryan Specialty, Kinsale Capital, and Casey's General Stores show strong asset-light, free-cash-flow-driven results, with revenue growth, margin gains, and analyst optimism supporting their outlooks.

You definitely do not want to toss it out or ignore it.

Apple began selling its latest premium smartphones Friday and analysts are cautiously optimistic about its prospects. Apple stock was flat.

Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief Financial Officer Clay Thornton said at Jefferies’ Healthcare Services and Technology Conference in

Check out the companies making headlines this week: Sabre (NASDAQ:SABR): Travel technology company Sabre (NASDAQ:SABR) rose by 9.6% on Wednesday after the co...

The PNT Price Trend moved upward during Q2 2026, with prices increasing across the major markets covered in this analysis. The main reason behind this move

Axsome is generating revenue from approved drugs but missing estimates and widening losses. Revolution Medicines just changed the standard of care for one of the deadliest cancers in existence.

We may not be in for a repeat of the last decade, but the odds of further gains are good.